OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	62
Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies	45
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	44
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	43
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	24
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	24
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	23
Deficits in our understanding of natural killer cell development in mouse and human	23
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy	19
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	17
Developmental regulation of primitive erythropoiesis	16
Regulation and importance of factor VIII levels in hemophilia A carriers	16
Mechanisms of immunothrombosis in COVID-19	16
Unraveling lipid metabolism for acute myeloid leukemia therapy	15
The impact of obesity-induced inflammation on clonal hematopoiesis	15
Splicing regulation in hematopoiesis	15
Disparities in acute myeloid leukemia treatments and outcomes	15
The new world: hematopoietic stem cell transplant during a pandemic	14
Congenital neutropenia: disease models guiding new treatment strategies	14
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications	13
Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia	12
Platelet lifespan and mechanisms for clearance	12
Editorial introductions	11
Significance and management of isolated distal deep vein thrombosis	10
Editorial introductions	10

Editorial introduction	10
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies	10
Editorial introductions	10
Understanding and targeting erythroid progenitor cells for effective cancer therapy	9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	9
Thrombosis in myeloproliferative neoplasms: update in pathophysiology	9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	9
Editorial introductions	9
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	9
Current Opinion in Hematology	8
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	8
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	8
Red blood cell changes due to cancer and cancer treatments: a narrative review	8
Editorial introductions	7
Modeling genetic platelet disorders with human pluripotent stem cells: mega-progress but wanting more on our plate(let)	7
The immunology of PF4 polyanion interactions	7
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	7
Translation defects in ribosomopathies	7
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	6
Modelling arterial thrombus formation in vitro	6
Models to study myelodysplastic syndrome and acute myeloid leukaemia	6
Chediak-Higashi syndrome	6
Editorial introduction	6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	6
The fulfilled promise and unmet potential of umbilical cord blood	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	6
Platelet transfusion	5
Immunomodulatory roles of red blood cells	5
Platelet mitochondria: the mighty few	5
Editorial introductions	4
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices	4
Red cell extracellular vesicles and coagulation activation pathways	4
Editorial introduction	4
Macrocytic anemias	4
The state of prediction models in hematologic disease: a worrisome assessment	4
Novel approaches to measure transfusion effectiveness	4
Recent advances in factor XII structure and function	4
Switching and increasing prophylaxis regimen with a genetically recombinant fusion of coagulation factor IX and albumin in haemophilia B: a case report	4
Prothrombotic state associated with preeclampsia	4
Epigenetics of hematopoietic stem cell aging	4
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications	4
The congenital dyserythropoieitic anemias: genetics and pathophysiology	4
Azacitidine maintenance in AML post induction and posttransplant	4
Editorial introduction	4
Donor selection in allogeneic stem cell transplantation	4
Pediatric acute myeloid leukemia – novel approaches	3
Scoring systems to predict thrombotic complications in solid tumor patients	3
Hematopoietic stem cell collection for sickle cell disease gene therapy	3
The impact of prenatal inflammation on hematopoietic development	3

Detecting and preventing post-hematopoietic cell transplant relapse in AML	3
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding	3
Brothers in arms: platelets and neutrophils in ischemic stroke	3
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease	3
Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis	3
Age-related micro-environmental changes as drivers of clonal hematopoiesis	3
N6-methyladenosine in hematological malignancies: a concise review	2
Direct megakaryopoiesis	2
The interplay between physical and mental health and its impact on outcomes for hemopoietic stem cell transplant patients	2
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases	2
Editorial Introductions	2
Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients	2
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance	2
Clonal hematopoiesis of indeterminate potential: recent developments and perspectives	2
Immunologic effects of red blood cell and platelet transfusions in neonates	2
Editorial introduction	2
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms	2
Histological differences among thrombi in thrombotic diseases	2
PIEZO1, sensing the touch during erythropoiesis	2
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease	2
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island	2
Factor XI as a therapeutic target in neuroinflammatory disease	2
Iron status of blood donors	2
Mouse models of vascular development and disease	2
Cellular components of the hematopoietic niche and their regulation of hematopoietic stem cell function	2
Circulating platelet count and glycans	2